Residency Program Director:

Contact Information: 
Phone: 916-734-3352
UC Davis Health
Inpatient Pharmacy
2315 Stockton Blvd, Room 1310
Sacramento, CA 95817

Andrea Iannucci, Pharm.D., BCOP
Assistant Chief Pharmacist, Oncology and
Investigational Drugs Services
Health Sciences Clinical Professor
UCSF School of Pharmacy and
UC Davis School of Medicine

2020-2021 Residents
Jenny Tran, Pharm.D.
Frank Oley, Pharm.D.
Amber Tang, Pharm.D.

ASHP Residency Directory:

Program Overview

The Oncology Pharmacy Specialty Residency at the University of California, Davis Medical Center, is a one-year, PGY2 specialty residency in Oncology Pharmacy Practice.  The residency is supported by the Department of Pharmacy.

Oncology is a strong, well-established and progressive center of excellence at UC Davis Health. The UC Davis Cancer Center is a Comprehensive Cancer Center, as designated by the National Cancer Institute.  Clinical Pharmacy Services at UCDH are provided in the areas of medical oncology, hematology, cellular therapy, pediatric oncology, investigational drugs service and at the UC Davis Cancer Center Infusion Rooms and clinics. The oncology specialty residency will provide residents with a comprehensive training and educational experience in oncology pharmacy.

UC Davis Health Pharmacy Department Mission

UC Davis Health Pharmacy's mission is to provide the highest quality and most cost-effective pharmaceutical care in an environment that fosters efficient patient-focused care, education and research.  Pharmaceutical care services are designed to meet the needs of our customers (primarily patients, nurses and physicians) in a way that constructively impacts all aspects of the medication use process (assessing, prescribing, dispensing, administering and monitoring). We will be flexible and proactive in our responsiveness to opportunities and challenges in the dynamic health-care field.

UC Davis Health PGY2 Oncology Pharmacy Residency Purpose

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. The purpose of the PGY2 Oncology Residency Program is to provide the PGY2 oncology residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete the PGY2 Oncology pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification in oncology pharmacy.

The aim of the UC Davis PGY2 Oncology Pharmacy Residency is to train oncology pharmacists to provide high quality, cost-effective, specialty care to patients with cancer and hematologic disorders in a positive learning environment that promotes independent, critical thinking, creativity and a culture of mutual respect.

Program Design

The major area of focus is adult Medical Oncology, with an emphasis on supportive care, antineoplastic drug pharmacology, management of patients with malignant and hematologic disorders, investigational cancer therapies, prevention and management of antineoplastic drug toxicities and medication safety in oncology pharmacy practice.  Oncology patient care is provided in multidisciplinary settings, and oncology pharmacy residents will interact with clinical pharmacists, pharmacy technicians, physicians, nurses, discharge planners, dietitians, patients, and caregivers to provide comprehensive care to patients with cancer. Daily activities will include coordinating chemotherapy ordering, chemotherapy preparation and administration activities, preventive and supportive management of cancer treatment-related complications, providing drug information to physicians, nurses and patients, medication reconciliation and coordination of home and discharge medications. 

The UC Davis Health PGY2 Oncology Residency is designed to meet the educational goals and objectives, as outlined by the ASHP PGY2 Oncology Residency Accreditation Standard.

Program Structure

The PGY2 Oncology Residency is a full-time, one-year commitment, typically beginning on July 1st and ending on June 30th.  Clearance to start work by UCDH Employee Health and a Human Resources orientation meeting must be completed prior to the established residency start date.

Proposed Calendar of Activities:

Quarter 1

Quarter 2

Quarter 3

Quarter 4


  • Orientation/training
  • Intake assessment
  • Establish residency goals/individualized development plan
  • Selection of research and Grand Rounds project topics


  • Clinical rotation
  • Weekly specialty clinic
  • MUE and other P&T activities should be identified


  • Clinical rotation
  • Weekly specialty clinic
  • Prepare research project progress for presentation at Bay Area Oncology Resident Research Forum


  • Clinical rotation
  • UC Collaborative Residency Conference


  • Clinical rotation
  • Preparation of research protocol


  • ASHP Mid-year Clinical Meeting (optional)
  • Conduct research
  • Prepare abstract for submission to HOPA


  • Clinical rotation
  • HOPA meeting


  • Clinical rotation
  • Weekly specialty clinic


  • Clinical rotation
  • Weekly specialty clinic
  • IRB submission of research project
  • Quarterly self and RPD assessments of longitudinal learning experiences and development plan


  • Clinical rotation
  • Weekly specialty clinic
  • Compile research project results and prepare draft presentation to RPD
  • Quarterly self and RPD assessments of longitudinal learning experiences and development plan


  • Clinical rotation
  • Weekly specialty clinic
  • Present draft research project presentation to RPD’s and pharmacy staff
  • Quarterly self and RPD assessments of longitudinal learning experiences and development plan


  • Clinical rotation
  • Weekly specialty clinic
  • End of residency closeout and completion of RPD and self-evaluations.

Longitudinal Activities with quarterly assessment

  • Residency research project
  • Teaching (integrated into learning experiences)
  • Weekend Oncology Service Coverage
  • Practice Management
  • Oncology Content/Patient Cases

UCDH PGY2 Oncology Residency Learning Experiences:
primarily be divided into block rotations and longitudinal learning experiences.  The majority of rotations will be 4 weeks in duration.  Rotation schedules will be determined based on availability and resident interests.  Rotation schedules will be adjusted and updated with the resident at each quarterly, summative evaluation.

Required Learning Experiences

Type of Experience



(4 weeks)
Orientation to UCDMC and PGY2 Oncology residency program. Preparation and training for weekend Oncology Service Coverage.

Inpatient Hematology/Oncology
(minimum of 2 rotations)

(4 weeks)
Clinical rotation with the inpatient medical oncology service. The resident will be assigned this rotation at least 2 times during the residency. Their role on the service will evolve as they gain more experience during their residency.

Stem Cell Transplant

(4 weeks)
Clinical rotation the stem cell transplant team. Includes inpatient service and weekly SCT clinic.

Pediatric Oncology

(6 weeks)
Clinical rotation with the pediatric oncology inpatient service and pediatric oncology clinics. Inpatient Pediatric Oncology Service 3 weeks; Outpatient Pediatric Oncology Infusion and hemophilia and sickle cell clinics.

Outpatient Infusion
and Clinics Block 1

(4 weeks)
Outpatient Infusion and Clinics Block 1 will focus on the fundamentals of the Infusion Pharmacy workflow, with an emphasis on oversight of preparation and dispensing of chemotherapy and investigational drugs. The resident will be introduced to the process of reviewing and processing of chemotherapy orders; management and prevention of chemotherapy-related toxicities; medication safety/preventing chemotherapy errors; patient counseling. The resident will also attend 1 or 2 half-day clinics to provide an overview of the ambulatory work flow in oncology patient care.

Outpatient Infusion and Clinics Block 2

(4 weeks)
The second Infusion and Clinic Rotation will focus on the coordination of activities in the Infusion Pharmacy. The emphasis will be focused on review and implementation of cancer treatment plans, including clinical trials orders.
GYN/ONC Concentrated 
(2 weeks)
The GYN/ONC rotation will include 2 weeks of inpatient GYN/ONC Service with GYN/Onc clinic. This learning experience will provide an overview of caring for patients with gynecologic malignancies.
Investigational Drugs Block
(4 weeks)
Provides overview of processes related to dispensing and managing investigational drugs. Duration may vary based on resident’s interests and availability.
Oncology Specialty Pharmacy Block
(4 weeks)
Provides focused learning in the management of patients on oral cancer-directed therapies. Provides the PGY2 Oncology resident with the opportunity to interact with patients, nurses and physicians in the initiation, procurement, assessment, management and follow-up of patients on oral cancer treatment regimens.
GI Oncology Clinic Concentrated 
(4 weeks)
Provides focused learning in the management of patients with GI malignancies, including colorectal, gastric, esophageal and pancreatic cancers. The resident will attend multiple GI oncology clinics over the course of their second outpatient oncology experience. They will also focus on implementation and preparation of chemotherapy regimens for patients with GI cancers. Overlaps with Infusion Block 2 LE.
Lung Cancer Clinic Concentrated
(4 weeks)
Provides focused learning in the management of patients with lung cancers. Includes 1 weekly clinic with a UCDMC lung cancer physician and participation in weekly Thoracic Tumor Board meeting. Overlaps with IDS LE
Breast Cancer Clinic Concentrated
(4 weeks)
Provides focused learning in the management of patients with breast cancer. Includes 1 weekly clinic with a UCDMC breast cancer physician and participation in weekly Breast Cancer Tumor Board meeting. Overlaps with Oncology Specialty Pharmacy LE.
GU Oncology Clinic Concentrated
(4 weeks)
Provides focused learning in the management of patients with GU malignancies, including prostate, renal cell, testicular and bladder cancers. Includes 1 weekly clinic with a UCDMC GU oncologist and participation in 3x per month GU Tumor Board meeting. Overlaps with Practice management block month.
Weekend Oncology Service Coverage Longitudinal (1 year) Alongside a residency preceptor, the oncology resident will provide coverage to the inpatient oncology services as part of the ~1:3 weekend rotation.
Oncology Pharmacy Practice Management Longitudinal 
(1 year)
Longitudinal learning experiences that captures many of the global and regulatory objectives of the PGY2 Oncology Residency training program, including medication management, compliance with USP and BOP requirements for handling hazardous drugs, oversight of learners and clinical teaching responsibilities. Includes 4 weeks of concentrated learning with Oncology Management Team.
Oncology Research Project Longitudinal 
(1 year)
Identification and completion of a research project in the area of oncology.

Elective Learning Experiences

Type of Experience



(4 weeks)
Clinical rotation focused on non-malignant hematologic disorders. Includes outpatient hemophilia, sickle cell and MDS clinics; inpatient specialty anticoagulation service.

Repeat or extension of any of the required learning experiences

(4 weeks)
The resident may choose to extend or repeat any of the required learning experiences, based on their interests.

Pain Management

(2 weeks)
Specialized experience in pain management in the inpatient setting. The resident will work with the pharmacy pain management specialist to provide consultative services for inpatients with acute and chronic pain. The resident will round with the pain service, write progress notes and provide recommendations in the EMR and monitor daily progress for patients on the service.

Palliative Care

(2 weeks)
Specialized experience in palliative care. The resident will round with the inpatient Palliative Care Service to provide recommendations on palliative and supportive care to hospital inpatients. The service provides comprehensive assessment and management of patients’ palliative care needs, including medication therapy, psycho-social support and ethical issues.

Nutrition Support

(2 weeks)
Specialized experience in nutrition support and parenteral nutrition. The resident will work with nutrition support pharmacy specialist and hospital dietitians to evaluate patients’ nutritional status and provide recommendations for nutrition support. The resident will provide recommendations in EMR progress notes for initiation and daily monitoring and adjustment of parenteral nutrition.

Infectious Diseases/Transplant ID

(2 weeks)
This experience may also be overlapped with a resident’s second SCT rotation. The resident will round with the ID and/or the Transplant ID service to obtained specialty experience in infectious diseases.

Topic Content:
The UC Davis Health PGY2 Oncology Residency is designed to provide the resident with a broad range of experiences in a variety of practice settings.  Required learning experiences have been designed to meet the content requirements, as outlined in the ASHP PGY2 Oncology Residency Accreditation Standard.  A content checklist and patient tracker is provided to each resident to document exposure to the required content and patient experiences.  This activity will be tracked and documented in PharmAcademic as a longitudinal learning experience.

UC Davis Health PGY2 Oncology Resident’s Role in Teaching:

UC Davis Health offers many opportunities for both clinical and didactic teaching. The resident will be responsible for assisting preceptors with clerkship teaching for University of California, San Francisco pharmacy students and UCDMC PGY1 pharmacy residents.  The resident will assume the primary preceptor role for UCSF pharmacy students during their last inpatient hematology/oncology learning experience.

The resident will be required to prepare an ACPE accredited pharmacy grand rounds presentation on an oncology topic, based on the resident’s interests and a department needs assessment.  The PGY2 Oncology Resident will also have the opportunity to participate in didactic teaching for the Medical Oncology/Hematology and Gynecological Oncology Fellows.  In addition, the PGY2 Oncology Resident may choose to participate in academic teaching, as requested by regional schools of pharmacy, with the approval of the PGY2 Oncology Residency Director.

Residency Research Project:
All UC Davis Health PGY2 residents are required to complete a research project during their residency and present their research at a regional, state or national conference.  In preparation for conducting their research project, the resident will be complete UC Davis Health IRB-required training and certification.  The resident will prepare a project proposal, which will be reviewed and approved by the UC Davis Health Pharmacy Research Oversight Committee.  The resident will also submit their project to the Pharmacy and Therapeutics Committee and the IRB for approval, before embarking on their research.  The resident will also be provided opportunities to present their research at one or more regional pharmacy residency conferences and submit their project as a poster presentation at a national pharmacy meeting (e.g. HOPA).  Upon completion of the project, the resident will be required to summarize their research project in a manuscript.

Pharmacy and Therapeutics Committee Activity:

The PGY2 Oncology resident will be required to participate in the Oncology Sub-Committee of the UC Davis Health Pharmacy and Therapeutics Committee.  The resident will also be required to complete the following activities for Oncology Sub-Committee:

  1. New oncology drug review/monograph
  2. MUE on oncology/supportive medication use or oncology guideline update

Additional assignments will be determined by the RPD in collaboration with the UC Davis Health P&T Committee coordinator, based on the resident’s interests, and the needs of the committee.

Grand Rounds:
The PGY2 Resident is required to prepare a Grand Rounds presentation on an oncology/hematology-related topic for the Department of Pharmacy staff.

Committee Assignments:
The PGY2 Oncology resident will participate in various committee activities, as assigned by the PGY2 oncology residency director. Assignments will be determined based on current department initiatives. The purpose of the resident’s committee involvement is to ensure the resident gains exposure to the oncology pharmacist’s role in activities related to quality-improvement, medication safety, safe handling of hazardous drugs, guideline development and assessment/implementation of technology and automation within the institution and pharmacy department. Committees in which oncology pharmacists play a key role at UCDMC include: Oncology Drugs Sub-Committee of the P&T Committee, Oncology Value Committee, SCT Quality Improvement Committee, UCDMC Cancer Committee.

Professional Development:
The PGY2 oncology resident is encouraged to maintain an active role in pharmacy and oncology professional organizations. The resident is strongly encouraged to become a member of the Hematology Oncology Pharmacists Association (HOPA) and attend their annual meeting in the early Spring. The resident will be provided with some financial support from the institution and professional leave time to facilitate participation in professional development activities.

Pharmacy Department Service:

The PGY2 oncology resident will be expected to provide ~400 hours of pharmacy department service. This expectation will be met primarily by providing oncology pharmacist coverage every third weekend plus one major holiday (Thanksgiving, Christmas Eve, Christmas Day or New Year’s Day). A back-up oncology pharmacist will always be available on site or on-call, to advise and support the PGY2 Oncology resident as needed. The resident will also be required to participate in the evening clinical support rotation with the other PGY1 and PGY2 residents (25 x 4-hour shifts).

Required Competencies:
Residents function as licensed pharmacist’s in patient care activities. As such, minimum knowledge in a variety of areas must be assured. Within one month of starting the Residency, the resident must complete competencies required of all clinical pharmacists. Additionally, if the resident does not already have ACLS certification, successful achievement of ACLS certification will be required.

Resident Portfolio:
Each resident must maintain a portfolio containing all information from the residency year including but not limited to: copies of papers or projects done during rotations, lectures given, research project manuscript, P&T drug monograph, and MUE. The portfolio shall be maintained in Pharm Academic and/or in the resident’s folder on the Pharmacy Department shared drive.

$59,500 annual salary. (Note that this salary includes a stipend for meeting registration, accommodations and travel for one professional meeting.)

Health, Dental and Vision insurance for resident and dependents; 21 days of Paid Time Off (PTO), 6 days Extended Sick Leave, and 4 days for Professional Development. Travel funds (~$2500) are included in the base salary. There is a stipend for Pharmacy Department scrubs.

Resident Personnel Policies:
The following policies can be located in the Pharmacy Resident Personnel Manual located at Davis Health-resident

  • Resident Qualifications
  • Early Commitment Policy
  • Pre-employment drug testing
  • Health insurance and Benefits
  • Moonlighting
  • Duty hours/tracking of duty hours
  • Professional, family, and extended leave policies
  • Dismissal policy and consequences of failure to progress

Criteria for Successful Completion of the PGY2 Oncology Residency

  • California license obtained per residency policy and completion of a minimum of 2/3 of the residency as a licensed CA Pharmacist
  • A minimum of 12 months training inclusive of standard vacation, professional and sick leave.
  • Completion of all required rotations/learning experiences
  • All required residency goals and objectives evaluated at least once, without any “needs improvement”. At least 80% of G&Os must be “Achieved for the Residency”. Some G&Os may be checked off by the RPD at resident closeout.
  • Resident closeout completed in PharmAcademic, confirming all tasks are completed
  • Completion of a research project, manuscript and manuscript submission for publication
  • Presentation of research project at a regional, state or national conference.
  • Drug monograph or other P&T activity completed
  • Completion of all required items on the Oncology Residency Content (topic discussion) Checklist and Patient Tracker
  • Completed staffing requirements as outlined by the residency program description
  • Pharmacy Grand Rounds presentation